FDA approves landmark pancreatic cancer drug that's shown to improve survival

Summary

U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.